The treatment of retinal diseases continue to evolve, providing the potential to enhance visual acuity and patient outcomes when incorporated in practice; however, staying up-to-date with these advances can be challenging. During this virtual meeting, experts in the field will review and discuss the progress being made in the management of retinal disease.

Objectives:
-Evaluate data from recent clinical trials of diabetic retinopathy treatments
-Discuss management strategies for dry and wet age-related macular degeneration
-Describe biosimilars that are being utilized and studied for retinal diseases